Kiadis Pharma is a global biopharmaceutical company. The headquarters is based in Amsterdam, The Netherlands. We focus on the treatment of blood cancers and inherited blood disorders aiming to make bone marrow transplantations safer and more efficient. We have a passionate team that is dedicated to make a huge difference for patients.
If you are up to the challenge and would like to be part of our team, we are currently looking for a Maintenance- or Reliability Engineer.
The maintenance Engineer will be responsible for the maintenance and maintenance scheduling for all company equipment and building facility and security systems. In this role you will coordinates and schedule (preventative) maintenance and repairs on equipment and building systems (e.g., cleanrooms, laboratory, and offices). You will evaluate and recommend equipment improvements to improve maintainability, performance and reliability. This can be the existing onsite equipment, but you will also be involved as a subject matter expert or project lead in the design and installation of newly built or refurbishments/changes of the building and equipment. We expect that you are be able to coordinate (and delegate) activities within the team or with external service providers. We will rely on your analytical thinking and communicative skillset to report and identify any actions that need to be taken.
Your responsibilities will be:
A challenging position in an innovative, fast growing biotechnology company.
You will be working in a fast-paced dynamic environment which provides the opportunity to make your own mark within the organization and build our ambitious HR team. You will be rewarded a competitive remuneration package, the opportunity for personal development and are able to contribute to make a huge difference for patients worldwide.
Kiadis Pharma is a clinical stage biopharmaceutical company developing innovative products to make bone marrow transplantations safer and more effective for patients. Kiadis Pharma believes that its innovative products have the potential to address the current risks and limitations connected with allogeneic hematopoietic stem cell transplantation (HSCT), thereby meeting a significant unmet medical need with its products.More about Kiadis Pharma